Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
58.57
+3.47 (6.30%)
At close: Aug 13, 2025, 4:00 PM
58.00
-0.57 (-0.97%)
After-hours: Aug 13, 2025, 7:44 PM EDT
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$410,118
Profits / Employee
-$204,759
Market Cap
7.30B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GH News
- 6 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 9 days ago - American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
- 13 days ago - Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 13 days ago - Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Benzinga
- 13 days ago - Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - Business Wire
- 14 days ago - Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+ - Business Wire
- 15 days ago - New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer - Business Wire